INTRA-CELLULAR THERAPIES INC COMMON STOCK
INTRA-CELLULAR THERAPIES INC COMMON STOCK is a security (CUSIP 46116X101) tracked across SEC portfolio filings. 1 institutional managers reported $3K on Form 13F as of 2026-03-31; 2 registered fund positions totaling $7.5M via N-PORT as of 2023-12-31.
Summary
- Issuer: INTRA-CELLULAR THERAPIES INC
- Class: COMMON STOCK
- CUSIP: 46116X101
- Asset category: EC
- 13F holders: 1
- 13F value: $3K
- 13F period: 2026-03-31
- N-PORT fund positions: 2
- N-PORT value: $7.5M
- N-PORT report: 2023-12-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| HUNTINGTON NATIONAL BANK | COLUMBUS, OH | $3K | 1 |
Top fund holders (N-PORT)
| Fund | Registrant | Value | % of fund |
|---|
| HARTFORD SMALL CAP GROWTH HLS FUND | HARTFORD HLS SERIES FUND II INC | $7.4M | 96.96% |
| Weiss Strategic Interval Fund | Weiss Strategic Interval Fund | $26K | 0.51% |
More